Cargando…
Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement
COVID-19 is a devastating respiratory and inflammatory illness caused by a new coronavirus that is rapidly spreading throughout the human population. Over the past 12 months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has already infected over 1...
Autores principales: | Coban, Mathew A., Morrison, Juliet, Maharjan, Sushila, Hernandez Medina, David Hyram, Li, Wanlu, Zhang, Yu Shrike, Freeman, William D., Radisky, Evette S., Le Roch, Karine G., Weisend, Carla M., Ebihara, Hideki, Caulfield, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224684/ https://www.ncbi.nlm.nih.gov/pubmed/34071060 http://dx.doi.org/10.3390/biom11060787 |
Ejemplares similares
-
Targeting an autocrine IL-6 – SPINK1 signaling axis to
suppress metastatic spread in ovarian clear cell carcinoma
por: Mehner, Christine, et al.
Publicado: (2020) -
Activity-based protein profiling reveals active serine proteases that drive malignancy of human ovarian clear cell carcinoma
por: Mehner, Christine, et al.
Publicado: (2022) -
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
por: Hayun, Hezi, et al.
Publicado: (2023) -
Utilizing genetic code expansion to modify N-TIMP2 specificity towards MMP-2, MMP-9, and MMP-14
por: Hayun, Hezi, et al.
Publicado: (2023) -
Engineering of tissue inhibitor of metalloproteinases TIMP-1 for fine discrimination between closely related stromelysins MMP-3 and MMP-10
por: Raeeszadeh-Sarmazdeh, Maryam, et al.
Publicado: (2022)